MedPath

Healing Touch During Chemotherapy Infusions for Women With Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Procedure: Healing Touch
Other: Standard care
Procedure: guided relaxation
Registration Number
NCT00533663
Lead Sponsor
Stanford University
Brief Summary

To study if Healing Touch is effective during chemotherapy treatment for breast cancer

Detailed Description

To study the effectiveness of Healing Touch provided during chemotherapy infusions on the experience of women undergoing treatment for breast cancer. Healing Touch (HT) is a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
32
Inclusion Criteria
  • Stage I or II breast cancer
  • Post-operative
  • Concurrent enrollment on a treatment protocol of 8 weeks of adriamycin + cyclophosphamide given every other week followed by 8 weeks of paclitaxel given every other week
  • ECOG Performance Status: 0 to 2
  • Speak and read English
Exclusion Criteria
  • Previous chemotherapy exposure

  • Concomitant energy-work interventions (HT, Reiki, QiGong, acupuncture).

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Standard Care + Healing Touch (HT)Standard careA a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy. It occurs every other week (during their infusion).
Standard Care + Healing Touch (HT)Healing TouchA a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy. It occurs every other week (during their infusion).
Standard Care + Guided relaxationguided relaxationGuided relaxation every other week (during their infusion).
Standard Care + Guided relaxationStandard careGuided relaxation every other week (during their infusion).
standard care onlyStandard careStandard care
Primary Outcome Measures
NameTimeMethod
FACT-B summary scoreBaseline, 6 wks, 14 wks
Secondary Outcome Measures
NameTimeMethod
Domain scores for FACT-B; BSI-18; FACIT-Fatigue; nausea measured on a Likert scaleBaseline, 6 wks, 14 wks

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath